MYCN and neuroblastoma: Fischer et al. reported that in patients with localized neuroblastoma, age 18 months or older, especially in INRG high-risk patients with MYCN amplification, extended surgery of the primary tumor site improved local control rate and survival with an acceptable risk of complications (Fischer et al. 2017).